Blood-Cleaning Device During Heart Surgery
Part of Heart & circulation clinical trials.
This trial tests a special blood-filtering device (Efferon LPS) used during heart surgery to reduce inflammation and improve recovery. The device removes harmful substances from your blood during the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having elective (planned) or emergency open-heart surgery that uses a heart-lung machine (cardiopulmonary bypass)
- Your EuroSCORE II surgical risk score is 6% or higher (your doctor can tell you this number)
- You do not have a blood infection marker (procalcitonin) level of 2 ng/mL or higher
- You do not have severe liver disease or liver failure
- You are not on dialysis or have end-stage kidney disease requiring dialysis
- You are not taking immunosuppressive drugs (like corticosteroids or chemotherapy agents) other than standard pre-surgery medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filter called Efferon LPS that removes harmful substances from the blood of people with severe burns. It aims to help the body recover by reducing inflammation and infection.
This trial tests whether a special blood filter (Efferon LPS) can help people with moderate to severe acute pancreatitis by removing harmful substances. It is for those who have been sick for 5 days or less and have certain signs of inflammation or organ stress.
This trial tests a blood-filtering device (Efferon LPS NEO) that removes harmful substances from the blood of children with severe thermal burns. It may help reduce complications and improve recovery.
This study tests a blood-filtering treatment (Efferon LPS) for people with severe thermal burns. The treatment may help remove harmful substances from the blood and reduce inflammation, potentially helping burns heal better.
This trial tests a new blood-filtering device called Efferon CT for people with cardiogenic shock after a heart attack. The device aims to help your body recover by cleaning harmful substances from your blood, and you might join if you are diagnosed early and don't have other serious health issues.
This study tests a blood-cleaning treatment to remove harmful toxins from the blood of people with severe abdominal infections. It might help their organs recover faster.
Hear when a new Cardiac Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.